Abstract
Alzheimer's disease is characterised by progressive difficulties in many areas of cognition and behavioural disturbance. The limited symptomatic treatments available currently are based on a detailed understanding of the neurochemical changes that in the brains of people with Alzheimer's disease and how they relate to specific symptoms. For example the mainstay of treatment, cholinesterase inhibitors, seeks to address presynaptic deficits in acetylcholine which underlie cognitive, attentional and behavioural aspects of the disorder.
| Original language | English |
|---|---|
| Title of host publication | Principles and Practice of Geriatric Psychiatry |
| Subtitle of host publication | Third Edition |
| Publisher | John Wiley and Sons |
| Pages | 299-303 |
| Number of pages | 5 |
| ISBN (Print) | 9780470747230 |
| DOIs | |
| State | Published - 2 Dec 2010 |
| Externally published | Yes |
Keywords
- Acetylcholine
- Behaviour
- Cognition
- Glutamate
- Neurochemistry
- Serotonin
Fingerprint
Dive into the research topics of 'Antemortem Markers'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver